Publication: 3267

Publication: 3267

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 38 (15_suppl) TPS5100

Meeting Instance:: ASCO 2020
Year:: 2020
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:: Health Outcomes

Pharmas:: Bristol-Myers & Exelixis
Grants:: UG1CA189823, U24CA196171

Corr. Author:
Authors:: Tian Zhang Karla Ballman Atish Choudhury Ronald C. Chen Colleen Watt Yujia Wen Ardaman Shergill Tyler Zemla Hamid Emamekhoo Ulka Vaishampayan Michael J. Morris Daniel J. George Toni K. Choueiri

Networks:: KANSAS, LAPS-IL057, LAPS-MA036, LAPS-NC010, LAPS-NY016, LAPS-TX011, LAPS-WI020

Study: Alliance-A031704
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: